| Literature DB >> 27540098 |
Ann John1, Chukwudi Okolie1, Alison Porter1, Chris Moore2, Gareth Thomas1, Richard Whitfield2, Rossana Oretti3, Helen Snooks1.
Abstract
BACKGROUND: Non-accidental non-fatal poisoning (NANFP) is associated with high risk of repeat episodes and fatality. This cross-sectional study aims to describe the data sources and epidemiology of non-fatal poisonings (NFPs) presenting to the emergency ambulance service.Entities:
Keywords: Drug abuse; EPIDEMIOLOGY; Emergency ambulance systems
Mesh:
Substances:
Year: 2016 PMID: 27540098 PMCID: PMC5013357 DOI: 10.1136/bmjopen-2016-011049
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Figure 1Calls categorised as non-fatal poisonings in the ambulance call centre and by ambulance crews on scene.
Number of overdose/poisoning codes assigned in the call centre and NANFP or treated with naloxone assigned on PCR forms
| Call centre subcategory code | Description | Number of call centre calls | Number of NANFP attendances from PCR (% of NFP call centre codes) |
|---|---|---|---|
| 23D01 | Unconscious | 477 | 158 (33.1) |
| 23D02 | Severe respiratory distress | 10 | 2 (0.2) |
| 23C01 | Violent | 497 | 200 (40.2) |
| 23C02 | Not alert | 675 | 176 (26.1) |
| 23C03 | Abnormal breathing | 299 | 69 (23.1) |
| 23C04 | Antidepressants | 121 | 52 (43.0) |
| 23C05 | Cocaine or derivative | 7 | 5 (71.4) |
| 23C06 | Heroin | 26 | 6 (23.1) |
| 23C07 | Acid or alkali | 3 | 2 (66.7) |
| 23C08 | Third party caller | 831 | 203 (24.4) |
| 23C09 | Poison control | 7 | 0 |
| 23B01 | Overdose without priority symptoms | 797 | 337 (42.3) |
| 23O01 | Poisoning without priority symptoms | 173 | 21 (12.1) |
| 23 other | 56 | ||
| Total | 3923 | 1287 |
NANFP, non-accidental non-fatal poisoning; NFP, non-fatal poisoning; PCR, patient clinical record.
Non-overdose codes assigned in the call centre to patients then coded by attending crews as non-accidental overdose/poisoning or treated with naloxone (n=540)
| Call centre code | Description | Number of NANFP calls from PCR data (% of all those miscoded or not labelled NFP at call) |
|---|---|---|
| 01 | Abdominal pain/problems | 4 (0.7) |
| 02 | Allergies | 2 (0.4) |
| 04 | Assault/sexual assault | 5 (0.9) |
| 05 | Back pain | 1 (0.2) |
| 06 | Breathing problems | 34 (6.3) |
| 09 | Cardiac/respiratory arrest | 18 (3.3) |
| 10 | Chest pain | 18 (3.3) |
| 12 | Convulsion/fitting | 28 (5.2) |
| 13 | Diabetic problems | 4 (0.7) |
| 17 | Falls | 15 (2.8) |
| 18 | Headache | 1 (0.2) |
| 19 | Heart problems | 4 (0.7) |
| 20 | Exposure | 1 (0.2) |
| 21 | Haemorrhage/laceration | 10 (1.9) |
| 22 | Industrial accident | 10 (1.9) |
| 25 | Psychiatric behaviour | 71 (13.1) |
| 26 | Sick person | 21 (3.9) |
| 27 | Stab/gunshot | 5 (0.9) |
| 28 | Stroke | 3 (0.6) |
| 29 | Traffic accident | 1 (0.2) |
| 30 | Traumatic injuries | 3 (0.6) |
| 31 | Unconscious/fainting | 73 (13.5) |
| 32 | Unknown problem | 19 (3.5) |
| Not known/not recorded | 189 (35.0) | |
| Total | 540 (100) |
NANFP, non-accidental non-fatal poisoning; NFP, non-fatal poisoning; PCR, patient clinical record.
Characteristics of incidents of non-accidental non-fatal poisoning, by substance(s) ingested
| Number of people who had taken substance | Female | Age | Reduced consciousness (GCS≤8) | Alcohol | Aggression or violence | Suicidal ideation | Police present | Refused treatment | Refused transport | Taken to hospital | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Substance | N (%) | N (%) | Mean | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) |
| Any | 1827 (100.0) | 991 (54.2) | 33.85 | 83 (4.5) | 844 (46.2) | 52 (2.9) | 147 (8.1) | 175 (9.6) | 20 (1.1) | 71 (3.9) | 1685 (92.2) |
| Psychotropics | 585 (32.0) | 322 (55.0) | 33.56 | 22 (3.8) | 316 (54.0) | 22 (3.8) | 62 (10.6) | 59 (10.1) | 6 (1.0) | 22 (3.8) | 559 (95.6) |
| Antidepressants | 322 (17.6) | 177 (55.0) | 33.55 | 12 (3.7) | 164 (50.9) | 15 (4.7) | 40 (12.4) | 37 (11.5) | 2 (0.6) | 10 (3.1) | 307 (95.3) |
| Benzodiazepines | 279 (15.3) | 157 (56.3) | 33.77 | 12 (4.8) | 162 (58.1) | 10 (3.6) | 30 (10.8) | 31 (11.1) | 4 (1.4) | 10 (3.6) | 267 (95.7) |
| Antipsychotics | 65 (3.6) | 37 (56.9) | 33.41 | 3 (4.6) | 24 (36.9) | 3 (4.6) | 2 (3.1) | 7 (10.8) | 2 (3.1) | 5 (7.7) | 62 (95.4) |
| Paracetamol | 484 (26.5) | 253 (52.3) | 34.85 | 29 (6.0) | 219 (45.3) | 19 (3.9) | 30 (6.2) | 47 (9.7) | 7 (1.5) | 24 (5.0) | 463 (95.7) |
| Opiates | 429 (23.5) | 240 (56.0) | 33.28 | 24 (5.6) | 181 (42.2) | 24 (5.6) | 42 (9.8) | 38 (8.9) | 5 (1.2) | 16 (3.7) | 397 (92.5) |
| Codeine | 266 (14.6) | 149 (56.0) | 34.65 | 16 (6.0) | 134 (50.4) | 15 (5.6) | 36 (13.5) | 25 (9.4) | 4 (1.5) | 7 (2.6) | 253 (95.1) |
| Diamorphine | 101 (5.5) | 59 (58.4) | 30.64 | 5 (5.0) | 25 (24.8) | 2 (2.0) | 3 (3.0) | 6 (5.9) | 0 (0.0) | 2 (2.0) | 88 (87.1) |
| Buprenorphine | 57 (3.1) | 30 (52.6) | 32.62 | 2 (3.5) | 20 (35.1) | 0 (0.0) | 3 (5.3) | 4 (7.0) | 1 (1.8) | 7 (12.3) | 53 (93.0) |
| Methadone | 14 (0.8) | 9 (64.3) | 26.50 | 2 (14.3) | 6 (42.9) | 0 (0.0) | 1 (7.1) | 2 (14.3) | 0 (0.0) | 1 (7.1) | 10 (71.4) |
| Morphine | 12 (0.7) | 7 (58.3) | 32.50 | 0 (0.0) | 4 (33.3) | 0 (0.0) | 0 (0.0) | 1 (8.3) | 0 (0.0) | 0 (0.0) | 12 (100.0) |
| NSAIDs | 223 (12.2) | 118 (52.9) | 35.15 | 8 (3.6) | 112 (50.2) | 8 (3.6) | 29 (13.0) | 20 (9.0) | 2 (0.9) | 6 (2.7) | 209 (93.7) |
| Ibuprofen | 154 (8.4) | 85 (55.2) | 36.28 | 4 (2.6) | 83 (53.9) | 4 (2.6) | 21 (13.6) | 13 (8.4) | 1 (0.7) | 6 (3.9) | 144 (93.5) |
| Aspirin | 47 (2.6) | 21 (44.7) | 33.68 | 2 (4.3) | 17 (36.2) | 0 (0.0) | 6 (12.8) | 4 (8.5) | 0 (0.0) | 0 (0.0) | 44 (93.6) |
| Diclofenac | 38 (2.1) | 20 (52.6) | 34.34 | 2 (5.3) | 20 (52.6) | 4 (10.5) | 3 (7.9) | 6 (15.8) | 1 (2.6) | 0 (0.0) | 36 (94.7) |
| Other known | 226 (12.4) | 130 (57.5) | 35.00 | 10 (4.4) | 100 (44.3) | 10 (4.4) | 7 (3.1) | 25 (11.1) | 2 (0.9) | 13 (5.8) | 208 (92.0) |
| Cocaine | 60 (3.3) | 29 (48.3) | 31.81 | 4 (6.7) | 35 (58.3) | 3 (5.0) | 0 (0.0) | 6 (10.0) | 1 (1.7) | 3 (5.0) | 54 (90.0) |
| Amphetamine | 36 (2.0) | 20 (55.6) | 37.23 | 0 (0.0) | 15 (41.7) | 1 (2.8) | 2 (5.6) | 5 (13.9) | 0 (0.0) | 1 (2.8) | 35 (97.2) |
| Cannabis | 36 (2.0) | 20 (55.6) | 35.21 | 1 (2.8) | 17 (47.2) | 3 (8.3) | 1 (2.8) | 4 (11.1) | 1 (2.8) | 0 (0.0) | 31 (86.1) |
| Ecstasy | 34 (1.9) | 17 (50.0) | 33.68 | 1 (2.9) | 22 (64.7) | 1 (2.9) | 0 (0.0) | 5 (14.7) | 0 (0.0) | 1 (2.9) | 31 (91.2) |
| Anticonvulsants | 32 (1.8) | 18 (56.3) | 37.76 | 2 (6.3) | 7 (21.9) | 0 (0.0) | 3 (9.4) | 2 (6.3) | 0 (0.0) | 0 (0.0) | 30 (93.8) |
| Cardiovascular | 23 (1.3) | 10 (43.5) | 33.05 | 3 (13.0) | 8 (34.8) | 0 (0.0) | 1 (4.4) | 2 (8.7) | 0 (0.0) | 0 (0.0) | 23 (100.0) |
| Antimicrobials | 16 (0.9) | 16 (100.0) | 37.53 | 0 (0.0) | 4 (25.0) | 0 (0.0) | 0 (0.0) | 3 (18.8) | 0 (0.0) | 5 (31.3) | 15 (93.8) |
| Indigestibles | 11 (0.6) | 10 (90.9) | 40.36 | 0 (0.0) | 5 (45.5) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 5 (45.5) | 10 (90.9) |
| Not known | 141 (7.7) | 68 (48.2) | 34.45 | 6 (4.3) | 14 (9.9) | 4 (2.8) | 8 (5.7) | 12 (8.5) | 0 (0.0) | 5 (3.6) | 126 (89.4) |
| Not stated | 47 (2.6) | 32 (68.1) | 34.22 | 0 (0.0) | 0 (0.0) | 0 (0.0) | 2 (4.3) | 6 (12.8) | 1 (2.1) | 3 (6.4) | 36 (76.6) |
Note: multiple ingestion was common; therefore, the sum for ingestion of individual substances does not add up to the collective total of the group to which the substance ingested belongs.
GCS, Glasgow Coma Scale; NSAIDs, non-steroidal anti-inflammatory drugs.